Reporting owner
Bodenstedt Matthias
Reporting owner CIK 0001920545 · Chief Financial Officer
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
1 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Dec 19, 2025 | MoonLake ImmunotherapeuticsClass A ordinary shares, par value $0.0001 per share | Bodenstedt Matthias | Conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | MoonLake ImmunotherapeuticsMLTX · company listings | Bodenstedt MatthiasChief Financial Officer | ConversionClass A ordinary shares, par value $0.0001 per shareNon-derivative security · Code C | 294,473 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
1 transaction on this page. Filing date, newest first.